Springer

SHERPA: Unknown

People

  1. Gounder
    Gounder
  2. Tap
    Tap
  3. D'Angelo
    D'Angelo
  4. Antonescu
    Antonescu
  5. Keohan
    Keohan
  6. Singer
    Singer
  7. Dickson
    Dickson
  8. Balachandran
    Balachandran
  9. Erinjeri
    Erinjeri
  10. Gonen
    Gonen

Groups

  1. Department of Medicine (40)
  2. Sarcoma Service (40)
  3. Solid Tumor Oncology Division (40)
  4. Surgery (12)
  5. Department of Pathology and Laboratory Medicine (11)
  6. GSK Faculty (11)
  7. Hematologic Malignancies, Division of (11)
  8. Tow Center for Developmental Oncology (TCDO) (11)
  9. Sarcoma Surgeons (10)
  10. Biostatistics Service (8)
Search Within
  1. "Sarcoma Service"
Formats
  1. Journal Article (30)
  2. Meeting Abstract (5)
  3. Review (3)
  4. Book Section (1)
  5. Book Whole (1)
Groups
  1. Department of Medicine (40)
  2. Sarcoma Service (40)
  3. Solid Tumor Oncology Division (40)
  4. Surgery (12)
  5. Department of Pathology and Laboratory Medicine (11)
  6. GSK Faculty (11)

More Groups

People
  1. Mrinal Gounder (14)
  2. William Tap (12)
  3. Sandra D'Angelo (9)
  4. Cristina Antonescu (8)
  5. Mary Keohan (7)
  6. Samuel Singer (7)

More People

Years
  1. 2025 (1)
  2. 2023 (4)
  3. 2022 (4)
  4. 2021 (3)
  5. 2020 (3)
  6. 2019 (7)

More Years

Publications
  1. Investigational New Drugs (11)
  2. Annals of Surgical Oncology (8)
  3. Cancer Chemotherapy and Pharmacology (4)
  4. Current Treatment Options in Oncology (4)
  5. Quality of Life Research (4)
  6. Immunotherapy of Sarcoma (2)

More Publications

Results (40)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tumor mitotic rate after neoadjuvant imatinib is associated with outcome in primary gastrointestinal stromal tumor (GIST)
    Meeting Abstract

    Cavnar, M. J.; Seier, K.; Mithat, G.; Balachandran, V. P.; Curtin, C.; Keohan, M.; Tap, W.; Antonescu, C.; Singer, S.; DeMatteo, R. P.
    Annals of Surgical Oncology (2019)

    Fulltext@MSK | Save
  • Exposure–response relationship of olaratumab for survival outcomes and safety when combined with doxorubicin in patients with soft tissue sarcoma
    Journal Article

    Jones, R. L.; Mo, G.; Baldwin, J. R.; Peterson, P. M.; Ilaria, R. L. Jr; Conti, I.; Cronier, D. M.; Tap, W. D.
    Cancer Chemotherapy and Pharmacology (2019)

    Fulltext@MSK | Save
  • Immune checkpoint inhibitors in sarcoma
    Book Section

    D'Angelo, S. P.; Kelly, C. M.
    In D'Angelo, S. P.; Pollack, S. M. (Eds.) Immunotherapy of Sarcoma (2018)

    Fulltext@MSK | Save
  • A phase 2 study of ontuxizumab, a monoclonal antibody targeting endosialin, in metastatic melanoma
    Journal Article

    D’Angelo, S. P.; Hamid, O. A.; Tarhini, A.; Schadendorf, D.; Chmielowski, B.; Collichio, F. A.; Pavlick, A. C.; Lewis, K. D.; Weil, S. C.; Heyburn, J.; more...
    Investigational New Drugs (2018)

    Fulltext@MSK | Save
  • A phase 1b dose expansion study of the pan-class I PI3K inhibitor buparlisib (BKM120) plus carboplatin and paclitaxel in PTEN deficient tumors and with dose intensified carboplatin and paclitaxel
    Journal Article

    Smyth, L. M.; Monson, K. R.; Jhaveri, K.; Drilon, A.; Li, B. T.; Abida, W.; Iyer, G.; Gerecitano, J. F.; Gounder, M.; Harding, J. J.; more...
    Investigational New Drugs (2017)

    Fulltext@MSK | Save
  • Rectal gastrointestinal stromal tumor (GIST) in the era of imatinib: Organ preservation and improved oncologic outcome
    Journal Article

    Cavnar, M. J.; Wang, L.; Balachandran, V. P.; Antonescu, C. R.; Tap, W. D.; Keohan, M.; Singer, S.; Temple, L.; Nash, G. M.; Weiser, M. R.; more...
    Annals of Surgical Oncology (2017)

    Fulltext@MSK | Save
  • Phase 1 study of narnatumab, an anti-RON receptor monoclonal antibody, in patients with advanced solid tumors
    Journal Article

    LoRusso, P. M.; Gounder, M.; Jalal, S. I.; André, V.; Kambhampati, S. R. P.; Loizos, N.; Hall, J.; Holzer, T. R.; Nasir, A.; Cosaert, J.; more...
    Investigational New Drugs (2017)

    Fulltext@MSK | Save
  • Relationship between physician-adjudicated adverse events and patient-reported health-related quality of life in a phase II clinical trial (NCT01143402) of patients with metastatic uveal melanoma
    Journal Article

    Atkinson, T. M.; Hay, J. L.; Shoushtari, A.; Li, Y.; Paucar, D. J.; Smith, S. C.; Kudchadkar, R. R.; Doyle, A.; Sosman, J. A.; Quevedo, J. F.; more...
    Journal of Cancer Research and Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Phase I study of XL281 (BMS-908662), a potent oral RAF kinase inhibitor, in patients with advanced solid tumors
    Journal Article

    Dickson, M. A.; Gordon, M. S.; Edelman, G.; Bendell, J. C.; Kudchadkar, R. R.; LoRusso, P. M.; Johnston, S. H.; Clary, D. O.; Schwartz, G. K.
    Investigational New Drugs (2015)

    Fulltext@MSK | Save
  • Additional primary malignancies in patients with gastrointestinal stromal tumor (GIST): A clinicopathologic study of 260 patients with molecular analysis and review of the literature
    Journal Article

    Hechtman, J. F.; DeMatteo, R.; Nafa, K.; Chi, P.; Arcila, M. E.; Dogan, S.; Oultache, A.; Chen, W.; Hameed, M.
    Annals of Surgical Oncology (2015)

    Fulltext@MSK | Save